Bluesight Hosts Third Diversion Symposium to Explore Key Topics Related to Drug Diversion Prevention
Bluesight Hosts Third Diversion Symposium to Explore Key Topics Related to Drug Diversion Prevention
ALEXANDRIA, Va.– On March 22nd, 2023 from 12 pm ET to 3pm ET, BluesightⓇ, The…
New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management
Survey of over 1,000 U.S. adults revealed 60.2% would switch hospitals if there was detected…
Medication Intelligence Leader Kit CheckⓇ Rebrands as BluesightⓇ
The shift redefines Bluesight from a point solution to a suite of Medication Intelligence™ software…
Kit Check Joins End Drug Shortages Alliance
Coalition aims to address drug shortages in the U.S., which hospital pharmacists identify as the…
Bluesight for Controlled Substances launching the Diversion Collective, a New Educational Resource for Successful Diversion Prevention Programs.
Bluesight for Controlled Substances launching the Diversion Collective, a New Educational Resource for Successful Diversion…
Kit Check’s Director of Clinical Strategy appointed to ASHP National Advisory Group.
Kit Check, the leader in Medication Intelligence™ solutions that bring cost savings, efficiency, and patient…
Kit Check Celebrates 1,000 Hospital Customer Milestone
The leading Medication Intelligence company has interacted with about 25% of acute and childrens’ hospitals…
Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes
ALEXANDRIA, Va.–(BUSINESS WIRE)–Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its…
Kit Check Customers Report The Most Success In Seeing Tangible Outcomes
Alexandria, VA. (June, 22, 2022)– Kit Check, the leading automation vendor in Medication Intelligence™ was…
Kit Check Recognized as Industry-Leading Vendor for Kit and Tray Management.
65% of participants consider Kit Check to be the top industry leader Washington, D.C. –…